insights_auto
Why is GH up 2,18%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
US$161,32
arrow_upward
+2,18%(+3,44) 1D
20 ຕ.ລ., 13 ໂມງ 47 ນາທີ 45 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$158,29
High
US$162,43
Low
US$155,07
Mkt. cap
21,65 ຕື້
Avg. vol.
1,80 ລ້ານ
Volume
652,09 ພັນ
52-wk high
US$191,01
52-wk low
US$66,59
EPS
US$-3,50
Beta
1,58
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
Open
US$158,29
High
US$162,43
Low
US$155,07
Mkt. cap
21,65 ຕື້
Avg. vol.
1,80 ລ້ານ
Volume
652,09 ພັນ
52-wk high
US$191,01
52-wk low
US$66,59
EPS
US$-3,50
Beta
1,58
Shares outstanding
134,20 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Stock Titan
·
4 ຊົ່ວໂມງກ່ອນ
Five short talks will explore blood-based cancer tests at ESMO, among 25 studies from Guardant and collaborators.
Investing.com Canada
·
14 ຊົ່ວໂມງກ່ອນ
Guardant Health director Tariq Musa sells $19,242 in stock By Investing.com
Stocks Down Under
·
23 ຊົ່ວໂມງກ່ອນ
Guardant Health (NDQ:GH): The Company Betting Its Cancer Screening Method Will Be Revolutionary!
Seeking Alpha
·
1 ມື້ກ່ອນ
Guardant Health: Growth Remains Too Expensive, Reiterate Hold (NASDAQ:GH)
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 ພັນ
Founded2012
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorHealth care provider
Websiteguardanthealth.com